HomeNURL • CNSX
add
Neural Therapeutics Inc
Previous close
$0.010
Day range
$0.015 - $0.015
Year range
$0.010 - $0.050
Market cap
2.53M CAD
Avg Volume
24.08K
P/E ratio
-
Dividend yield
-
Primary exchange
CNSX
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Jan 2026info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 81.89K | -31.33% |
Net income | -390.76K | -237.33% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Jan 2026info | Y/Y change |
|---|---|---|
Cash and short-term investments | 62.79K | -88.51% |
Total assets | 1.64M | 193.78% |
Total liabilities | 988.11K | -0.93% |
Total equity | 653.22K | — |
Shares outstanding | 168.70M | — |
Price to book | ∞ | — |
Return on assets | -11.30% | — |
Return on capital | -12.50% | — |
Cash Flow
Net change in cash
| (CAD) | Jan 2026info | Y/Y change |
|---|---|---|
Net income | -390.76K | -237.33% |
Cash from operations | -52.01K | -597.35% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -52.01K | -111.45% |
Free cash flow | -18.55K | 88.79% |
About
Founded
2020
Headquarters
Website
